1st-line treatment of patients with high-grade non-Hodgkin’s lymphoma: Similar effectiveness with R-CHOP-14 or R-CHOP-21 – Data from the German prospective TLN Registry.

Knauf, W., Abenhardt, W., Mohm, J., Rauh, J., Grugel, R., Harde, J., Jänicke, M., Marschner, N., 2015.

Oncol Res Treat 38 (suppl 5)(V75), 19. doi:10.1159/000439070

Studie: TLN; Indikation: Hämoblastosen; Jahr: 2015; Veranstaltung: DGHO; Journal: Oncology Research and Treatment

iOMEDICO AG
Ellen-Gottlieb-Straße 19
79106 Freiburg

Tel: 0761 - 15 242 0
E-Mail: info@iomedico.com